Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

What happened

Max Hodak, the former president and co-founder of Neuralink, detailed onstage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).

Why it matters

The development may change operating conditions or market expectations around AI. Further confirmation and measurable outcomes matter.

Affected entities

View evidence

1 reports · 1 original report · 1 independent

1. TechCrunch AIPrimary source · Supports · EN · 100%
   Science Corporation implants its vision-restoring chip in its first Stargardt disease patient ↗Oct 13, 2026, 7:13 PM

Claims

• Science Corporation implants its vision-restoring chip in its first Stargardt disease patient Observed

Conflicts

No material conflict detected in the available evidence.

Timeline

1. October 13, 2026 at 7:13 PMFirst reported

Market move following event

Market reaction is not yet available for this asset and time window.

Score explanation